Latest News for Abivax Stock (OTC:AAVXF)

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

News

Intraday Update

Markets

Movers

Trading Ideas

AAPL

AAVXF

ADBE

ADYYF

AFGC

AHCHY

AIQUY

ALFVY

ARES

ASGN

ASGTF

ASML

ASND

ATBYF

ATEYY

ATGN

ATXI

AUPH

AXAHY

AZMTF

BABA

BKFKF

BMRPF

BOLD

BOOT

BTBIF

BURBY

BXMT

CATM

CBRE

CDAY

CGEN

CGPZF

CHNG

CHTR

CODI

CROX

CRUS

CSTL

CTRN

CWXZF

CYDY

DGDM

DIOD

DNNGY

DSDVY

DYFSF

EDPFY

EPAM

ESPR

Eaton Vance Tax-Advantaged Global Dividend

EXPGY

FBMS

FERGY

FFMR

FGBI

FICO

Stocks That Hit 52-Week Highs On Friday

ACRE

ADYEY

AGRO

AKZOF

AMWD

ANGPY

ARWGF

ASMLF

ASPN

ATEC

AUDC

BALMF

BANF

BBDC

BBSEY

BFGIF

BPOP

BRBR

BRKL

BSRR

BSVN

BUSE

CACI

CARO

CCBG

CGJTF

CHOLF

CHRRF

CNOB

COHU

COLB

CPLP

CREIY

CSGKF

CTBI

CVCY

CYFL

DEER

EBSB

EDIT

New Oriental Education & Technology Group

EFSC

EPAY

EPOKY

EXPGF

FBAYF

FBHS

FBNC

FCCT

FFWM

FLEX

FMNB

FNLC

FORM

FTGFF

GABC

GAIN

GBCI

GBLBF

GMED

GRKZF

GVDNY

HHSE

HNGR

HTLF

Stocks That Hit 52-Week Highs On Wednesday

AACAY

AAUKF

ABCZY

ACLS

ADSK

AHEXY

AHFD

AINV

ALGT

AMGN

AMIGF

AMIGY

AMKBF

AMRN

AMTB

ANSLF

APAM

ARGKF

ARGX

ARNC

AROW

ASBFY

ASNB

ATDRY

ATLKY

ATVI

AXSM

BAESY

BCKIF

BCLYF

BNPQY

BNTX

BRK-A

BRK-B

BTDPY

BTLCY

BTSGY

CBSH

CDUAF

CHDN

CIFAF

CLSD

CODGF

CODYY

CRAI

CRD-A

CRHCF

Stocks That Hit 52-Week Highs On Tuesday

Abivax SA

Piper Sandler analyst Charles Neivert maintains Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Underweight and lowers the price target from $32 to $29.

Price Target

Analyst Ratings

Piper Sandler Maintains Underweight on Mosaic, Lowers Price Target to $29

Piper Sandler analyst Charles Neivert maintains CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) with a Underweight and lowers the price target from $82 to $75.

Piper Sandler Maintains Underweight on CF Industries Holdings, Lowers Price Target to $75

Telsey Advisory Group analyst Dana Telsey maintains Children's Place (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLCE#NASDAQ">PLCE</a>) with a Market Perform and lowers the price target from $13 to $9.

PLCE

Telsey Advisory Group Maintains Market Perform on Children's Place, Lowers Price Target to $9

Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) shares are trading higher after reporting first-quarter results. The company is <a href="https://www.benzinga.com/premarket" target="_blank" rel="noreferrer noopener">reducing revenue expectations for its HEYDUDE unit.</a>
The company reported adjusted earnings per share of $3.02,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/n38664195/crocs-inc-reports-first-quarter-fiscal-2024-financial-results" rel="noreferrer noopener">beating the analyst consensus of $2.23.&nbsp;</a>
Quarterly revenues of $939 million beat the street view of $881.712 million. First&nbsp;quarter revenue increased 6% over&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">last year.</a>
In the quarter under review, Crocs held inventories&nbsp;worth&nbsp;$392 million&nbsp;compared to&nbsp;$476 million a year ago.
Segment-wise,&nbsp;Crocs Brand&nbsp;revenues increased by 14.6% to&nbsp;$744 million, or 15.6% on a constant currency basis, while&nbsp;HEYDUDE&nbsp;brand revenues decreased by 17.2% to&nbsp;$195 million.
&nbsp;&#8220;As we continue to prioritize brand health in the North American market for HEYDUDE, and considering what we are seeing quarter-to-date, we are reducing our revenue expectations for the brand for the&nbsp;balance of the year,&#8221; said&nbsp;Andrew Rees, Chief Executive Officer.&nbsp;
Direct-to-consumer revenues grew 11.8%, or 12.3%, on a constant currency basis. Wholesale revenues grew 3.2%, or 4.1%, on a constant currency basis.
Adjusted gross margin improved 180 basis points to 56.0% compared to 54.2%. Adjusted income from operations of $255 million increased 3.1% from $247 million, resulting in an adjusted operating margin of 27.1%.
The company exited the quarter with cash and equivalents&nbsp;of&nbsp;$159 million&nbsp;compared to&nbsp;$126 million a year ago.
Outlook:&nbsp;Crocs expects second-quarter adjusted diluted earnings&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">per share of&nbsp;$3.40&nbsp;to&nbsp;$3.55 versus the $3.47 estimate.</a>&nbsp;
The company sees second-quarter revenues&nbsp;to be&nbsp;up 1%-3% compared to the second quarter of 2023. Crocs Brand&nbsp;is expected&nbsp;to grow 7% to 9% on a&nbsp;year over year&nbsp;basis in the second quarter. HEYDUDE Brand is likely to contract (19%) to (17%) year over year.
For FY24, the company raised adjusted diluted earnings per share&nbsp;outook, which is expected&nbsp;in the range of&nbsp;$12.25&nbsp;to&nbsp;$12.73 versus the $12.43 estimate (prior view: $12.05 to $12.50).&nbsp;The company&nbsp;continues to expect&nbsp;full-year 2024 revenue growth of 3% to 5%&nbsp;year over year. Revenues for the&nbsp;Crocs Brand&nbsp;is&nbsp;expected&nbsp;to grow approximately 7% to 9% (prior view: 4% to 6%).&nbsp;Revenues for the&nbsp;HEYDUDE Brand&nbsp;to&nbsp;now&nbsp;contract&nbsp;(10%) to (8%) (prior view: &nbsp;flat to slightly up).
&#8220;We are confident in the long-term opportunity for the HEYDUDE brand and are excited to welcome a&nbsp;<a target="_blank" href="https://www.benzinga.com//node/38266762" rel="noreferrer noopener">new HEYDUDE President&nbsp;to fully unlock its future potential</a>,&#8221; Rees added.
Crocs also announced the appointment of&nbsp;Susan Healy&nbsp;as Executive Vice President and&nbsp;<a target="_blank" href="https://www.benzinga.com//node/38664249" rel="noreferrer noopener">Chief Financial Officer, effective&nbsp;June 3.</a>&nbsp;Healy succeeds&nbsp;Anne Mehlman, who was recently appointed President of the Crocs Brand.
Price Action: CROX shares are trading higher by 9.77% to $138.00 at last check Tuesday.
Photo via Wikimedia Commons

Earnings

Equities

Guidance

Crocs Stock Surges Despite HEYDUDE's Bumpy Ride - Details Here

Stephens &amp; Co. analyst Matt Breese maintains Fulton Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FULT#NASDAQ">FULT</a>) with a Equal-Weight and raises the price target from $15.5 to $17.5.

FULT

Stephens & Co. Maintains Equal-Weight on Fulton Financial, Raises Price Target to $17.5

By <a href="https://roboforex.com/?utm_source=benzinga.com&amp;utm_medium=pr&amp;utm_campaign=rf_en_external_article_07052024&amp;utm_content=analysis&amp;utm_term=forecast">RoboForex</a> Analytical Department
Brent crude oil is seeing a slight increase on Tuesday, priced around $83.57 per barrel. The market remains close to two-month lows, caught between optimism for a peaceful resolution to the Middle East conflict and concerns over crude oil inventories in the United States.
The primary focus in the stock market currently revolves around the ongoing negotiations between Israel and Hamas, facilitated by Egypt. However, these talks have hit an impasse, and there are renewed signs of conflict from both parties. Israel has expressed dissatisfaction, stating that the terms offered do not meet its demands, thereby complicating diplomatic efforts.
Despite these challenges, the ongoing conflict in the Middle East contributes to supporting energy prices due to fears of potential disruptions in raw material supplies. On the demand side, Saudi Arabia has recently increased its oil selling prices to Asian buyers, indicating an expectation of robust demand, particularly during the upcoming summer. This adjustment is often seen when a producer is confident about expanding demand, with Saudi Arabia likely counting on strong consumption from China, the world&#39;s leading oil importer.
<h3>Brent Technical Analysis</h3>
<a href="https://www.benzinga.com/files/u117641/brenth4_45.png"><img alt="" src="https://www.benzinga.com/files/u117641/brenth4_45.png" style="height:280px; width:624px" /></a>
On the H4 chart, Brent has achieved the local target of the growth wave at 91.50. The correction towards 82.70 is nearing completion, and we anticipate the formation of a consolidation range above this level. Should the price break upwards from this range, a new wave of growth towards $95.00 could be initiated. This bullish scenario is technically supported by the MACD indicator, which shows the signal line at the lows under the zero mark, indicating potential growth to new highs.
<a href="https://www.benzinga.com/files/u117641/brenth1_44.png"><img alt="" src="https://www.benzinga.com/files/u117641/brenth1_44.png" style="height:280px; width:624px" /></a>
On the H1 chart, the structure of the fifth wave of correction to 82.70 has been formed. A consolidation range has developed above this level, and we expect a growth link to 84.44. Should this level be surpassed, it could open the potential for a growth wave to 85.70, which is the initial target. This technical outlook is corroborated by the Stochastic oscillator, with its signal line above 20 and prepared to ascend to 80.
Disclaimer
Any forecasts contained herein are based on the author&#39;s particular opinion. This analysis may not be treated as trading advice. RoboForex bears no responsibility for trading results based on trading recommendations and reviews contained herein.
This article is from an unpaid external contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Commodities

General

Brent Crude Oil Experiences Modest Uptick Amid Mixed Market Signals

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Abivax Stock (OTC:AAVXF)

Friday, December 27, 2019

Wednesday, December 18, 2019

Monday, December 16, 2019

Friday, December 13, 2019

Wednesday, December 11, 2019